Mathai Mammen

Senior VP, Research, Innoviva, Inc.

Companies

Parabilis Medicines, Inc.Board member Jun 9, 2026 to now¹
Parabilis Medicines, Inc.Chief executive officer Jun 9, 2026 to now¹
Parabilis Medicines, Inc.President Jun 9, 2026 to now¹
10X GenomicsBoard member Sep 11, 2019 to Jun 13, 2024²
Johnson & JohnsonEVP, Pharm, R&D Jan 13, 2022 to Feb 17, 2022³
Theravance Biopharma, Inc.SVP, Research & Early Clin Dev Oct 10, 2014 to Mar 17, 2016⁴
Innoviva, Inc.Senior VP, Research Jan 11, 2008 to Aug 22, 2014⁵

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 11, 2024Granted 8,649 shares of 10X Genomics⁶
Jun 14, 2023Granted 1,865 shares of 10X Genomics⁸
May 11, 2023Sold 33,000 shares at $52.82 of 10X Genomics⁹
May 11, 2023Exercised options 200,000 shares at $1.16 of 10X Genomics⁹
Jun 15, 2022Granted 2,120 shares of 10X Genomics¹⁰
Feb 15, 2022Shares withheld for tax 3,366 shares at $165.89 of Johnson & Johnson⁷
Feb 15, 2022Exercised options 7,740 shares of Johnson & Johnson⁷
Feb 14, 2022Shares withheld for tax 2,335 shares at $168.85 of Johnson & Johnson¹¹
Feb 14, 2022Exercised options 7,418 shares of Johnson & Johnson¹¹

The numbers on this page point here. Each one links to the record it came from.